financetom
Business
financetom
/
Business
/
--Wesco International Keeps Quarterly Dividend of $0.4125 a Share, Payable June 28 to Shareholders as of June 14
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Wesco International Keeps Quarterly Dividend of $0.4125 a Share, Payable June 28 to Shareholders as of June 14
May 31, 2024 1:53 AM

04:04 AM EDT, 05/31/2024 (MT Newswires) --

Price: 184.99, Change: +6.13, Percent Change: +3.43

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China's military, state media slam U.S. after Reuters report on SpaceX spy satellites
China's military, state media slam U.S. after Reuters report on SpaceX spy satellites
Mar 18, 2024
BEIJING, March 18 (Reuters) - Chinese military and state-run media on Sunday accused the United States of threatening global security, days after a Reuters report which found Elon Musk's SpaceX was building hundreds of spy satellites for a U.S. intelligence agency. SpaceX's Starshield unit is developing the satellite network under a classified $1.8 billion contract with the National Reconnaissance Office...
Alibaba groceries arm Freshippo CEO to step down
Alibaba groceries arm Freshippo CEO to step down
Mar 18, 2024
BEIJING, March 18 (Reuters) - Freshippo, the groceries arm of e-commerce giant Alibaba Group ( BABA ), told staff that its CEO Hou Yi would retire, according to an internal letter seen by Reuters on Monday. Current CFO Yan Xiaolei will take on the CEO role, while Hou will continue as consultant to the company, the letter said. ...
Fennec Pharmaceuticals Signs Exclusive Licensing Deal With Norgine
Fennec Pharmaceuticals Signs Exclusive Licensing Deal With Norgine
Mar 18, 2024
05:32 AM EDT, 03/18/2024 (MT Newswires) -- Fennec Pharmaceuticals ( FENC ) and Norgine said Sunday that they have signed an exclusive licensing agreement to commercialize Pedmarqsi, which is intended for the prevention of hearing loss induced by cisplatin chemotherapy in patients one month to less than 18 years old with localized, non-metastatic solid tumors. Under the agreement, Norgine will...
Nasdaq says investigating issues impacting connectivity
Nasdaq says investigating issues impacting connectivity
Mar 18, 2024
March 18 (Reuters) - Exchange operator Nasdaq said on Monday it was investigating issues impacting connectivity to the exchange. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved